U2AF1L4
Basic information
Region (hg38): 19:35742463-35745445
Previous symbols: [ "U2AF1L3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the U2AF1L4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 3 | 0 |
Variants in U2AF1L4
This is a list of pathogenic ClinVar variants found in the U2AF1L4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-35742636-A-G | not specified | Uncertain significance (Dec 17, 2023) | ||
19-35742645-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
19-35742674-G-A | not specified | Likely benign (Aug 22, 2023) | ||
19-35742689-T-C | not specified | Uncertain significance (Oct 05, 2021) | ||
19-35742753-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
19-35742798-G-A | not specified | Uncertain significance (Apr 22, 2022) | ||
19-35743812-C-A | not specified | Uncertain significance (Apr 25, 2022) | ||
19-35743812-C-T | not specified | Likely benign (Jan 19, 2024) | ||
19-35743830-T-C | not specified | Uncertain significance (Nov 29, 2021) | ||
19-35743863-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
19-35743871-C-A | not specified | Uncertain significance (Jul 25, 2023) | ||
19-35743880-G-C | not specified | Uncertain significance (Nov 17, 2023) | ||
19-35743899-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
19-35744102-C-T | not specified | Likely benign (Jan 12, 2024) | ||
19-35744106-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
19-35744120-C-G | not specified | Uncertain significance (Apr 10, 2023) | ||
19-35744142-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
19-35744325-T-C | not specified | Uncertain significance (Aug 01, 2022) | ||
19-35744364-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
19-35744378-T-C | not specified | Uncertain significance (Jul 20, 2021) | ||
19-35745158-G-C | not specified | Uncertain significance (Sep 13, 2023) | ||
19-35745166-C-A | not specified | Uncertain significance (Oct 10, 2023) | ||
19-35745181-C-A | not specified | Uncertain significance (Dec 19, 2022) | ||
19-35745384-T-C | not specified | Uncertain significance (May 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
U2AF1L4 | protein_coding | protein_coding | ENST00000292879 | 6 | 2982 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000671 | 0.291 | 125643 | 2 | 103 | 125748 | 0.000418 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.309 | 137 | 127 | 1.08 | 0.00000708 | 1308 |
Missense in Polyphen | 23 | 29.101 | 0.79036 | 333 | ||
Synonymous | 0.545 | 48 | 53.1 | 0.905 | 0.00000342 | 412 |
Loss of Function | 0.0896 | 8 | 8.28 | 0.966 | 3.50e-7 | 100 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000324 | 0.000324 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000357 | 0.0000352 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00291 | 0.00288 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein that function as a pre-mRNA splicing factor. Plays a critical role in both constitutive and enhancer- dependent splicing by mediating protein-protein interactions and protein-RNA interactions required for accurate 3'-splice site selection. Acts by enhancing the binding of U2AF2 to weak pyrimidine tracts. Also participates in the regulation of alternative pre-mRNA splicing. Activates exon 5 skipping of PTPRC during T-cell activation; an event reversed by GFI1. Binds to RNA at the AG dinucleotide at the 3'-splice site (By similarity). Shows a preference for AGC or AGA (By similarity). {ECO:0000250|UniProtKB:Q8BGJ9}.;
- Pathway
- Shigellosis - Homo sapiens (human);Spliceosome - Homo sapiens (human);Gene expression (Transcription);RNA Polymerase II Transcription;Metabolism of RNA;Cleavage of Growing Transcript in the Termination Region ;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing;mRNA 3,-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Intolerance Scores
- loftool
- 0.470
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.64
Haploinsufficiency Scores
- pHI
- 0.0884
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.547
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.653
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- U2af1l4
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- mRNA splicing, via spliceosome;RNA export from nucleus;mRNA export from nucleus;mRNA 3'-end processing
- Cellular component
- nucleoplasm;spliceosomal complex;cytoplasm;nuclear speck;U2AF
- Molecular function
- pre-mRNA 3'-splice site binding;metal ion binding